Health ❯ Pharmacology ❯ Drug Development

Clinical Trials

Efficacy Studies Therapeutics Animal Studies Ambroxol SCoR2 Inhibitors TNIK Inhibitor INS018_055 MA-5 Toxicology Tirzepatide Research BaxHTN Trial Preclinical Trials FDA Approved Drugs FDA-Approved Treatments NAD+ Modulating Supplements Thiorphan Rac1 Inhibitors Lemborexant

Berkeley Compound TOFA Cuts Fat in Obese Mice by Raising Energy Use

By increasing whole‑body energy expenditure, TOFA produced large fat loss in mice and could complement appetite‑reducing GLP‑1 drugs.

Tirzepatide Cuts Alcohol Drinking and Relapse-Like Behavior in Rodent Study

Anti-Seizure Drug Levetiracetam Blocks Early Alzheimer’s Protein Production, Study Finds

Semaglutide Curbs Cocaine Use and Relapse-Seeking in Rats, Peer-Reviewed Study Finds

Baxdrostat Lowers Blood Pressure in Hard-to-Treat Patients in Phase III Trial

Ambroxol Trial Confirms Safety, Brain Delivery and Early Cognitive Benefits in Parkinson’s Dementia